These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35438741)

  • 41. [Analysis of FDA medical device recall in 2005-2006].
    Zhang Q; Liu S; Yan Y; Fang P
    Zhongguo Yi Liao Qi Xie Za Zhi; 2011 Jul; 35(4):280-3. PubMed ID: 22097754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical device reporting: issues with Class III medical devices.
    Zigler J; Walsh J; Zigler J
    Food Drug Law J; 2007; 62(3):573-80. PubMed ID: 17915398
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient safety. Recalled. Now what.
    Haugh R
    Hosp Health Netw; 2006 Dec; 80(12):12, 14. PubMed ID: 17236443
    [No Abstract]   [Full Text] [Related]  

  • 45. Mapping the genealogy of medical device predicates in the United States.
    Pai DB
    PLoS One; 2021; 16(10):e0258153. PubMed ID: 34618861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical device recalls: get it right the first time: Comment on "Medical device recalls and the FDA approval process".
    Redberg RF; Dhruva SS
    Arch Intern Med; 2011 Jun; 171(11):1011-2. PubMed ID: 21321286
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study on Informatization of Medical Device Administration in China].
    Chen L; Li M
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Jul; 41(4):275-278. PubMed ID: 29862788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical devices on trial, Part I.
    Wright D
    Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Devising new tactics. Providers and medical device manufacturers struggle to find best ways to work together on recalls, advisories.
    Mantone J
    Mod Healthc; 2006 May; 36(19):24-6. PubMed ID: 16711236
    [No Abstract]   [Full Text] [Related]  

  • 50. Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
    Heneghan CJ; Goldacre B; Onakpoya I; Aronson JK; Jefferson T; Pluddemann A; Mahtani KR
    BMJ Open; 2017 Dec; 7(12):e017125. PubMed ID: 29212782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmaceuticals and medical devices: medical devices.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-38. PubMed ID: 22403842
    [No Abstract]   [Full Text] [Related]  

  • 52. Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across food and drug administration device categories.
    Ghobadi CW; Janetos TM; Tsai S; Welty L; Walter JR; Xu S
    Issues Law Med; 2019; 34(1):77-92. PubMed ID: 31179672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Food and Drug Administration. Surveillance and medical devices.
    Tomkinson A; Harrison W; Temple M; Phillips P
    BMJ; 2010 Dec; 341():c6999. PubMed ID: 21138999
    [No Abstract]   [Full Text] [Related]  

  • 54. How to deal with recalled prosthetic devices.
    Rifai A; McInerney VK
    Orthopedics; 2014 Jan; 37(1):40-1. PubMed ID: 24410304
    [No Abstract]   [Full Text] [Related]  

  • 55. Total recall. Providers are taking the lead in revamping system for handling questionable drugs and medical devices.
    Lee J
    Mod Healthc; 2011 Aug; 41(32):28, 30. PubMed ID: 21879697
    [No Abstract]   [Full Text] [Related]  

  • 56. The Bleeding Edge: Documenting Innovation and Injury in the Medical Device Industry.
    Pendyal A; Ross JS
    JAMA; 2019 Jul; 322(3):190-192. PubMed ID: 31310276
    [No Abstract]   [Full Text] [Related]  

  • 57. Medical devices; reports of corrections and removals; lift of stay of effective date--FDA. Final rule; lift of stay of effective date.
    Fed Regist; 1998 Apr; 63(73):18836. PubMed ID: 10179315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA Netw Open; 2020 Aug; 3(8):e2014496. PubMed ID: 32857145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed scrutiny: Reported problems with birth control device expose gaps in FDA post-market surveillance.
    Rice S
    Mod Healthc; 2015 Jul; 45(30):16-8. PubMed ID: 26510278
    [No Abstract]   [Full Text] [Related]  

  • 60. Warning! AbTox sterilizers recalled--FDA is on the case.
    Blyth PL
    Mater Manag Health Care; 1998 Jun; 7(6):16. PubMed ID: 10183406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.